Iridian Asset Management LLC Alaunos Therapeutics, Inc. Transaction History

Iridian Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 03, 2020	SELL	$3.95 - $5.35 $133,857 - $181,300	-33,888 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$4.13 - $6.94 $139,957 - $235,182	33,888 New	33,888 $145,000
Q2 2019 Jul 31, 2019	SELL	$3.98 - $6.2 $381,837 - $594,821	-95,939 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$2.0 - $4.4 $191,878 - $422,131	95,939 New	95,939 $369,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Iridian Asset Management LLC with notifications on news.